Search Results
336 items found for "protease-activated receptors (PARs)"
- Involvement of Protease-Activated Receptor2 Pleckstrin Homology Binding Domain in Ovarian Cancer: Expression in Fallopian Tubes and Drug Design
< GPCR News < GPCRs in Oncology and Immunology Involvement of Protease-Activated Receptor2 Pleckstrin While the involvement of G-protein-coupled receptors (GPCRs) in cancer is growing, GPCR-based therapies Here, we demonstrate the overexpression of protease-activated receptor 2 (PAR2), a GPCR member in the It attenuates PAR2 oncogenic activity. , protease-activated receptors (PARs) Source Contribute to the GPCR News Coming soon Become a Contributor
- Ep 54 with Dr. JoAnn Trejo
San Francisco under the guidance of Professor Shaun Coughlin where she worked on the newly discovered protease-activated Trejo’s research program is to gain a thorough and mechanistic understanding of processes that control cell signaling by protease-activated receptors (PARs) and the impact on vascular inflammation and cancer PARs are GPCRs that are activated through an atypical irreversible proteolytic mechanism. Her laboratory is the recognized expert on protease-activated receptors, particularly PAR1, and over
- Ep 125 with Dr. Gregory Tall
the common example known at the time, protease activated receptors (PARs). PARs have an N-terminal leader sequence that is clipped by exogenous proteases to reveal a new N-terminus Adhesion GPCRs pre-cleave themselves and the two resultant fragments of the receptor remain together adhesion GPCRs in complex physiological contexts…one being our discovery that GPR56 is the platelet receptor that senses collagen and shear force to initiate the platelet activation program.
- Ep 151 with Dr GPCR Board
GPCR, an ecosystem designed to bring together stakeholders interested in using G-Protein Coupled Receptors San Francisco under the guidance of Professor Shaun Coughlin where she worked on the newly discovered protease-activated cell signaling by protease-activated receptors (PARs) and the impact on vascular inflammation and cancer PARs are GPCRs that are activated through an atypical irreversible proteolytic mechanism. Her laboratory is the recognized expert on protease-activated receptors, particularly PAR1, and over
- Metallo-protease Peptidase M84 from Bacillusaltitudinis induces ROS-dependent apoptosis in ovarian cancer cells by targeting PAR-1
< GPCR News < GPCRs in Oncology and Immunology Metallo-protease Peptidase M84 from Bacillusaltitudinis This metallo-protease had no discernible impact on normal cell survival, but it specifically induced We observed that Peptidase M84 induced PAR-1 overexpression along with activating its downstream signaling This established Peptidase M84 as a drug candidate for receptor mediated targeted-therapy of ovarian and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation
- Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19
< GPCR News < GPCRs in Oncology and Immunology Increased protease-activated receptor 1 autoantibodies and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation
- Autocrine proteinase-activated receptor signaling in PC3 prostate cancer cells
< GPCR News < GPCRs in Oncology and Immunology Autocrine proteinase-activated receptor signaling in PC3 prostate cancer cells Published date June 29, 2023 Abstract "Proteinase-activated receptors (PARs) are G protein-coupled receptors (GPCRs) activated by limited n-terminal proteolysis. Specific activators of PARs in different physiological and pathophysiological contexts remain poorly and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation
- Trainee Symposium II
Activated Receptor (PAR) Cleavage to Osteoarthritis (OA) Severity About Amr Mousa "I am currently a Schulich School of Medicine and Dentistry, Western University, researching the molecular mechanisms of Proteinase-Activated Receptors (PARs) in osteoarthritis. receptors (GPCRs) and G protein activation. GPCR Title: Development of a Transgenic Mouse Platform for the Detection of Endogenous G protein Activity
- Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration
< GPCR News < GPCRs in Oncology and Immunology Simultaneous activation of CXC chemokine receptor 4 and histamine receptor H1 enhances calcium signaling and cancer cell migration Published date February 1 , 2023 Abstract "C-X-C chemokine receptor 4 (CXCR4) is widely overexpressed in various types of cancer Simultaneous activation of CXCR4 and HRH1 synergistically increases calcium flux in MDA-MB-231 cells and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation
- Single cell G-protein coupled receptor profiling of Transcription factor 21 expressing activated kidney fibroblasts
< GPCR News < GPCRs in Oncology and Immunology Single cell G-protein coupled receptor profiling of Transcription and purpose: Activated fibroblasts deposit fibrotic matrix in chronic kidney disease (CKD) and G-protein coupled receptors (GPCRs) are the most druggable therapeutic targets. The adenosine receptors, Adora2a/2b were upregulated in Tcf21+ fibroblasts and the adenosine receptor Tags Adenosine receptor , Fibroblast , Fibrosis , GPCR , Kidney , Tcf21 .
- Signaling by Neutrophil G Protein-Coupled Receptors that Regulate the Release of Superoxide Anions
< GPCR News < GPCRs in Oncology and Immunology Signaling by Neutrophil G Protein-Coupled Receptors that Neutrophils, which express many receptors that are members of the large family of G protein-coupled receptors and fatty acids activate FPR2 and GPR84, respectively. The activation profiles of these receptors include the release of reactive oxygen species (ROS) generated Activation of the oxidase and the production of ROS are processes that are regulated by proinflammatory
- Chemoattractant receptor signaling in humoral immunity
< GPCR News < GPCRs in Oncology and Immunology Chemoattractant receptor signaling in humoral immunity receptors (GPCRs) responding to chemoattractants, represented by chemokines. C termini, which dictates functional outcomes of β-arrestin-mediated signaling, ranging from receptor inactivation to effector molecule activation. and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation
- Minireview: functional roles of tissue kallikrein, kinins, and kallikrein-related peptidases in lung cancer
One approach to treating patients suffering from lung cancer is to target surface receptors overexpressed on tumor cells, such as GPCR-family kinin receptors, and proteases that control tumor progression, such These proteases have been visualized in recent years due to their contribution to the progression of Considering the multiple functions of kinin receptors and KLKs, this review highlights their roles, even and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation
- Stimulation of ectopically expressed muscarinic receptors induces IFN-γ but suppresses IL-2 production by inhibiting activation of pAKT pathways in primary T cells
Previously, we reported that the G-protein-coupled human muscarinic receptor could bypass tyrosine kinases Here, we demonstrate that stimulating G-protein-coupled muscarinic receptors (M1 and synthetic hM3Dq) can activate primary mouse T cells if PLCβ1 is coexpressed. Stimulation of muscarinic receptors induced strong nuclear translocation of NFAT and NFκB and activated Tags GPCR; T cells; muscarinic receptor; signaling.
- DANGER Signals Activate G-Protein Receptor Kinases Suppressing Neutrophil Function and Predisposing to Infection After Tissue Trauma
< GPCR News < GPCRs in Oncology and Immunology DANGER Signals Activate G-Protein Receptor Kinases Suppressing Mitochondrial (mt) formyl peptides (FP) activate G-protein coupled receptors (GPCR) like FPR1. mtDNA and heme activate toll-like receptors (TLR9, TLR2/4). GPCR kinases (GRKs) can regulate GPCR activation. GRK2 activation via TLR9 prevented actin reorganization, implicating histone deacetylases (HDACs).
- Neuroimmune interplay during type 2 inflammation: symptoms, mechanisms and therapeutic targets in atopic diseases
The consequences of altered neuroimmune activity differ with tissue type and disease and include: skin -31 receptor A , Interleukin-33 receptor , Interleukin-4 receptor alpha , Interleukin-5 receptor alpha receptor 11 , Mas-related family of G protein-coupled receptor X1 , Mas-related family of G-protein-coupled receptor 3 , Mas-related family of G-protein-coupled receptors , Mitogen-activated protein kinase , subunit beta , PAR2 , PC(20) , PN , Protease activated receptor 2 , Provocative concentration causing
- From odor to oncology: non-canonical odorant receptors in cancer
< GPCR News < GPCRs in Oncology and Immunology From odor to oncology: non-canonical odorant receptors Alongside the canonical GPCR odorant receptors, dysregulation of non-canonical odorant receptors such as trace amine-associated receptors (TAARs), formyl peptide receptors (FPRs), and membrane-spanning tumorigenesis and others acting as tumor-suppressing factors upon activation, depending on the cancer and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation
- Olfactory Receptors and Tumorigenesis: Implications for Diagnosis and Targeted Therapy
< GPCR News < GPCRs in Oncology and Immunology Olfactory Receptors and Tumorigenesis: Implications for Diagnosis and Targeted Therapy Published date October 4, 2024 Abstract "Olfactory receptors (ORs) are a class of G protein-coupled receptors (GPCR) widely distributed in olfactory sensory neurons and various Authors Yi Tang, Ye Tian, Chun-Xia Zhang, Guo-Tai Wang Tags G Protein-coupled receptors , Olfactory receptors and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
< GPCR News < GPCRs in Oncology and Immunology C5aR2 receptor: The genomic twin of the flamboyant C5aR1 C5a is established to interact with a set of genomically related transmembrane receptors, like C5aR1 The C5aR1 is a classical G-protein-coupled receptor (GPCR), whereas C5aR2 is a nonclassical GPCR that tailors immune cell activity potentially through β-arrestins rather than G-proteins. Authors Aurosikha Das, Pulkit K Gupta, Soumendra Rana Tags C5a; C5aR2/C5L2 receptor; lipid bilayer; molecular
- G Protein-coupled Receptor-mediated Membrane Targeting of PLCγ2 is Essential for Neutrophil Chemotaxis
< GPCR News < GPCRs in Oncology and Immunology G Protein-coupled Receptor-mediated Membrane Targeting receptors (GPCRs) activate β phospholipase C (PLCβ) while receptor tyrosine kinases (RTKs) activate ; elevated GSK3 phosphorylation and cofilin activation; impaired dynamics of actin polymerization; and Tags G protein-coupled receptor (GPCR) , calcium-promoted Ras inactivator (CAPRI) , chemotaxis , neutrophils and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation
- Intermediate-state-trapped mutants pinpoint G protein-coupled receptor conformational allostery
intermediate states in signaling is pivotal to unraveling the activation processes of G protein-coupled receptors (GPCRs). adenosine A 2A receptor (A 2A R), a class A GPCR. A GPCR activation process based on the well-discerned conformational states is thus proposed, allosterically Intermediate-state-trapped mutants will also provide useful information in relation to receptor-G protein
- Interplay between G protein-coupled receptors and nanotechnology
< GPCR News < GPCRs in Oncology and Immunology Interplay between G protein-coupled receptors and nanotechnology Published date July 28, 2023 Abstract "G protein-coupled receptors (GPCRs), as the largest family of membrane receptors, actively modulate plasma membrane and endosomal signalling. overexpression of GPCRs on the surface of various types of cells, GPCR ligands can endow nanoparticles with active targeting capacity for specific cells via ligand-receptor binding and mediate receptor-dependent endocytosis
- Agonists of galanin subtype 2 receptor may prevent pancreatic cancer and agonists of angiotensin II type 2 receptor may prevent colorectal cancer
) receptor inhibited the growth of GAL2 receptor-expressing patient-derived xenografts (PDX) of pancreatic with high GAL2 receptor expression. for GAL2 receptor agonists. also known as Angiotensin-II type 2 receptor-Interacting Protein. and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation
- Activation of orphan receptor GPR132 induces cell differentiation in acute myeloid leukemia
< GPCR News < GPCRs in Oncology and Immunology Activation of orphan receptor GPR132 induces cell differentiation Here, we showed that genetic activation of the orphan GPCR GPR132 significantly induced cell differentiation Notably, GPR132 activation by 8GL promoted differentiation and reduced colony formation in human AML (mTOR), a regulator of AML cell differentiation blockade, via activating GPR132-Gs-PKA pathway. In summary, this study demonstrated that activation of orphan GPR132 represents a potential strategy
- Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed by Single-Molecule Analysis of their Conformational Landscapes
CXCR4 and atypical receptor ACKR3 both respond to CXCL12 but induce different effector responses to The receptors also have distinct activation requirements. conformations, consistent with its propensity for activation. CXCR4 active-state. This and the markedly different conformational landscapes of the receptors suggest that activation of
- Role and recent progress of P2Y12 receptor in cancer development
< GPCR News < GPCRs in Oncology and Immunology Role and recent progress of P2Y12 receptor in cancer development Published date June 14, 2024 Abstract "P2Y12 receptor (P2Y12R) is an adenosine-activated G protein-coupled receptor (GPCR) that plays a central role in platelet function, hemostasis, and thrombosis. P2Y12R activation can promote platelet aggregation and adhesion to cancer cells, promote tumor angiogenesis and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation
- Interrogating Multiscale Receptors Functions in Space
Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Interrogating Multiscale Receptors for Beta-arrestin signaling in the brain in vivo and has established its importance in D2 dopamine receptors These receptors belong to the super-family of G-protein coupled receptors (GPCR), the major molecular (e.g. lithium) used for bipolar disorder therapy target signaling mechanisms regulated by dopamine receptors In addition to basic research, the Beaulieu group is also actively implicated in translational research
- Identification of Small-Molecule Antagonists Targeting the Growth Hormone Releasing Hormone Receptor (GHRHR)
(GHRHR) Published date August 29, 2024 Abstract "The growth hormone-releasing hormone receptor (GHRHR ) belongs to Class B1 of G protein-coupled receptors (GPCRs). in activation. These compounds were validated in vitro using a cyclic adenosine monophosphate (cAMP) ELISA to measure activity and Taste GPCRs in Oncology and Immunology Structural and molecular insights into GPCR function GPCR Activation